Artiva Biotherapeutics, Inc. SEC filings ARTV
Artiva Biotherapeutics, Inc. has 232 filings in SEC EDGAR's recent list, going back to Jul 10, 2020. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, exit or restructuring costs). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 11, 2026 | — |
| S-3 | Shelf registration | Aug 6, 2026 | — |
| 424B5 | Prospectus supplement | May 8, 2026 | — |
| FWP | Free writing prospectus | May 8, 2026 | — |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| S-3 | Shelf registration | Aug 6, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| S-8 | Employee stock plan registration | Jul 22, 2024 | — |
| 424B4 | Prospectus | Jul 22, 2024 | — |
| S-1MEF | Filing | Jul 18, 2024 | — |
| S-1/A | Amended registration statement | Jul 15, 2024 | — |
| S-1 | Registration statement | Jun 28, 2024 | — |
| S-1/A | Amended registration statement | Jun 6, 2022 | — |
| S-1/A | Amended registration statement | Mar 7, 2022 | — |
| S-1/A | Amended registration statement | Jan 21, 2022 | — |
| S-1/A | Amended registration statement | Dec 16, 2021 | — |
| S-1 | Registration statement | Apr 8, 2021 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ARTV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1817241
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.